Factors Linked to Moderate-to-Severe Ulcerative Colitis: Insights from a Retrospective Case-Control Analysis

• by Chenfei Zhang, Xiaoling Huang

• March 12, 2026

Refining Vancomycin Use in Early CDI

A modified dosing approach could reshape recurrence prevention strategies.

• by Julia Cipriano, MS, CMPP

• March 4, 2026

• 2 min

The innovation trap: How pharma weaponizes a word to extend monopolies

• by Tahir Amin, Rohit Malpani

• May 26, 2026

REACHing forward—a strategic vision for ECCO and the future of IBD care

• by Britta Siegmund, Ailsa Hart

• February 14, 2026